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Abstract
While the number of reported tuberculosis (TB) cases in the United States has declined
over the past two decades, TB morbidity among foreign-born persons has remained persis-
tently elevated. A recent unexpected decline in reported TB cases among foreign-born per-
sons beginning in 2007 provided an opportunity to examine contributing factors and inform
future TB control strategies. We investigated the relative influence of three factors on the
decline: 1) changes in the size of the foreign-born population through immigration and emi-
gration, 2) changes in distribution of country of origin among foreign-born persons, and 3)
changes in the TB case rates among foreign-born subpopulations. Using data from the U.S.
National Tuberculosis Surveillance System and the American Community Survey, we
examined TB case counts, TB case rates, and population estimates, stratified by years
since U.S. entry and country of origin. Regression modeling was used to assess statistically
significant changes in trend. Among foreign-born recent entrants (<3 years since U.S.
entry), we found a 39.5% decline (-1,013 cases) beginning in 2007 (P<0.05 compared to
2000–2007) and ending in 2011 (P<0.05 compared to 2011–2014). Among recent entrants
from Mexico, 80.7% of the decline was attributable to a decrease in population, while the
declines among recent entrants from the Philippines, India, Vietnam, and China were
almost exclusively (95.5%–100%) the result of decreases in TB case rates. Among foreign-
born non-recent entrants (3 years since U.S. entry), we found an 8.9% decline (-443
cases) that resulted entirely (100%) from a decrease in the TB case rate. Both recent and
non-recent entrants contributed to the decline in TB cases; factors contributing to the
decline among recent entrants varied by country of origin. Strategies that impact both recent
and non-recent entrants (e.g., investment in overseas TB control) as well as those that
focus on non-recent entrants (e.g., expanded targeted testing of high-risk subgroups
among non-recent entrants) will be necessary to achieve further declines in TB morbidity
among foreign-born persons.
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Introduction
Tuberculosis (TB) remains an enormous public health challenge globally, with 9.6 million new
cases and 1.5 million deaths each year [1]. Meanwhile, the United States has experienced a
steady decline in TB cases over the past 2 decades, with a record low number of TB cases in
2014 [2]. This decline has predominately been among U.S.-born persons; the number of cases
among foreign-born persons has remained relatively constant, and the TB case rate among the
foreign-born population was 13.4 times greater than that of the U.S.-born population in 2014
[2]. A recent model estimated that TB elimination in the United States will not be achieved
within the 21st century, partly because of a persistently elevated rate of TB among foreign-born
persons [3].
Recent analyses revealed an unexpected decline in cases among foreign-born persons in the
United States that began in 2007 [4, 5]. We investigated the relative influence of three factors
on this decline: changes in the size of the foreign-born population through immigration and
emigration, changes in the distribution of country of origin among foreign-born persons, and
changes in the TB case rates among specific foreign-born subpopulations. We hypothesized
that the decline among foreign-born persons was primarily because of a decreased rate of TB
among recent entrants into the United States, a decreased number of foreign-born persons liv-
ing in the United States (particularly recent entrants), and to a lesser extent, a decrease in trans-
mission among foreign-born persons in the United States secondary to the lower number of
cases due to the former two reasons.
Methods
Study Population
The study population included all foreign-born persons in the United States during 2000–
2014. On the basis of preliminary findings, analyses of the decline focused on the period 2007–
2011. Verified cases of reported TB were from the U.S. National Tuberculosis Surveillance Sys-
tem, which includes both laboratory-confirmed cases and clinical cases meeting pre-specified
criteria [6]. Cases were classified by the patient’s country of origin and years since U.S. entry.
Cases with unknown data regarding the patient’s country of origin or years since U.S. entry
were excluded from the analysis. Genotyping data were from the U.S. National Genotyping
Service [7]. Population estimates were derived from the American Community Survey 1-year
estimates, an ongoing statistical survey that samples approximately 1.9 million households
annually [8], and has been utilized for previous studies of TB case rates among foreign-born
persons in the United States [9–11]. Individuals are included in the American Community Sur-
vey regardless of immigration status [8]. Data from the U.S. Department of Homeland Security
[12] and CDC’s Electronic Disease Notification system [13] were used to estimate the number
persons who entered into the United States in a given year, stratified by visa type and country
of origin.
Data Analysis
Joinpoint regression software, version 4.2.0.2 (National Cancer Institute, Bethesda, Maryland)
was used to identify statistically significant changes in trend among TB case counts [14, 15].
Annual TB case rates were calculated by using case counts and population estimates for each
year and were expressed as the number of cases per 100,000 persons. Detailed methods used to
calculate rates stratified by years since U.S. entry have been described elsewhere [9–11].
Previous studies have established the high morbidity and elevated TB case rates among for-
eign-born persons during the first few years after entry into the United States [9–11, 16, 17].
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To provide greater detail on these first few years, we divided foreign-born persons into the
following groups based upon time since U.S. entry:<1 year,1 to<2 years,2 to<3 years,
3 to<6 years, and6 years. We then concentrated further subpopulation analyses on recent
entrants, defined as foreign-born persons<3 years since U.S. entry, as this represents the pop-
ulation most affected by changes in immigration and emigration [8, 18, 19]. We examined TB
cases among recent entrants from the top five countries accounting for the largest number of
cases diagnosed in the United States (i.e., Mexico, Philippines, India, Vietnam, and China) [2].
After excluding cases from the top five countries of origin, we categorized the remaining cases
of TB among recent entrants according to the TB incidence in the country of origin as follows:
low,<15 cases/100,000 persons; medium, 15–99 cases/100,000 persons; or high incidence,
100/100,000 persons [1].
To evaluate potential causes of the decline among each foreign-born subpopulation, we esti-
mated the proportion of the case count decrease resulting from changes in the TB case rate ver-
sus population shifts using Formula 1 and Formula 2 below. If there was an increase in
population from 2007 to 2011, then 100% of the case count decline was assumed to be the
result of changes in TB case rate.
Formula 1. Percent of case count decline resulting from TB case rate change =
P2007  ðR2011  R2007Þ
P2007  ðR2011  R2007Þ þ R2007  ðP2011  P2007Þ
R2007 = TB case rate in 2007; R2011 = TB case rate in 2011; P2007 = Population in 2007;
P2011 = Population in 2011
Formula 2. Percent of case count decline resulting from population change =
R2007  ðP2011  P2007Þ
P2007  ðR2011  R2007Þ þ R2007  ðP2011  P2007Þ
R2007 = TB case rate in 2007; R2011 = TB case rate in 2011; P2007 = Population in 2007;
P2011 = Population in 2011
In 2007, CDC updated requirements for overseas TB screening of refugees and persons apply-
ing for permanent resident visas to the United States [20, 21]. Among the most important changes
was the introduction of routine mycobacterial culture (in addition to the already required spu-
tum-smear microscopy). Those applying for other visa types (e.g., students, exchange visitors,
temporary workers, tourists, and business travelers) are not routinely required to undergo over-
seas TB screening, and those who enter the United States without a visa (e.g., undocumented per-
sons) are not subject to overseas screening. We used data from the U.S. Department of Homeland
Security and CDC’s Electronic Disease Notification system to assess the scope of overseas TB
screening by estimating the number of persons each year who arrived as refugees or permanent
resident applicants. We then used American Community Survey data to estimate the overall pop-
ulation of new entrants, defined as the population that entered the United States within the past
year, regardless of visa type (including persons without a visa). For each country, we calculated
the proportion of the new entrant population who passed through culture-based overseas TB
screening during 2007–2011. For countries where culture-based overseas screening only occurred
for part of a year [22], we assumed that the number of refugees and permanent resident applicants
was evenly distributed by month and prorated the number screened accordingly.
Finally, focusing on cases among recent entrants (<3 years since U.S. entry), we estimated the
number of cases associated with likely recent transmission in the United States. We used a meth-
odology verified against a field-based standard [23], with two alterations. First, we included cases
diagnosed<100 days after U.S. entry to avoid underestimating cases possibly due to local
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transmission shortly after arrival. Second, a case attributed to recent transmission must have had
a U.S. entry date before the diagnosis date of the possible source case. The U.S. National Geno-
typing Service introduced universal 24-locus mycobacterial interspersed repetitive unit–variable
number tandem repeat genotyping in 2009 [7]. To ensure a 2-year time interval for a potential
source case to be identified, the transmission component of the analysis was limited to cases
counted during January 1–September 30, 2011, in the U.S. National Tuberculosis Surveillance
System. Cases diagnosed during October 1–December 31, 2011, were excluded to allow an addi-
tional 3-month period for belated identification of potential source cases. A given case was classi-
fied as due to recent transmission if at least one plausible source case was identified based upon
clinical characteristics, genotyping data, and temporal and geographic proximity to the putative
secondary case. In addition, we examined the reported origin (U.S.-born versus foreign-born) for
each potential source case. Some secondary cases were found to have more than one potential
source case; therefore, we generated low and high estimates of possible source cases by origin.
Aside from analyses of Joinpoint regression and changes in trend, all additional analyses
were conducted using SAS, version 9.3 (SAS Institute, Inc., Cary, North Carolina). For all sta-
tistical tests, results were considered to be significant at P<0.05. CDC reviewed the proposed
study and determined that approval by an institutional review board was not required because
data were collected and analyzed for this project as part of routine TB surveillance; therefore,
the project is not considered research involving human subjects.
Results
Trends in TB Case Counts, 2000–2014
There were 108,944 cases of TB reported among foreign-born persons in the United States dur-
ing 2000–2014. Data were missing for country of origin or time since U.S. entry for 4,913 per-
sons (4.5%), leaving 104,031 cases for analysis. TB cases among recent entrants (<3 years since
U.S. entry) declined by 42.9% (-1,148 cases) during 2000–2014, with statistically significant
changes in trend in 2007 and 2011 (Fig 1). In 2014, recent entrants accounted for 26.2% of all
cases among foreign-born persons, compared with 37.0% in 2000.
Time since U.S. Entry, 2007–2011
During 2007–2011, there was an overall decline of 1,456 cases (-19.3%) among all foreign-born
persons (Table 1). Among recent entrants (<3 years since U.S. entry), there were decreases in
case count (-39.5%, -1,013 cases), TB case rate (-30.8%), and population (-12.5%). Among non-
recent entrants (3 years since U.S. entry), there was a decrease in case count (-8.9%, -443 cases)
and TB case rate (-16.6%), but an increase in the non-recent entrant population (+9.1%).
When examining more discrete groups by years since U.S. entry (Fig 2), case counts
declined among all groups, with the smallest relative case count decline among foreign-born
persons in the United States6 years (-7.0%, -276 cases). TB case rates also declined among all
foreign-born groups, regardless of time since U.S. entry (Table 1). Although the population of
foreign-born persons with6 years since U.S. entry increased (+11.4%), decreases in popula-
tion were seen among all other groups.
Recent Entrants: Top Five Countries of Origin, 2007–2011
TB case counts among recent entrants from all of the top five countries of origin declined dur-
ing 2007–2011 (Fig 3). The largest relative declines in case counts were among recent entrants
fromMexico (-56.1%, -270 cases), the Philippines (-52.5%, -180 cases), and India (-39.8%,
-101 cases).
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When examining TB case rates, the greatest relative declines occurred among recent
entrants from the Philippines (-51.3%), India (-47.3%), China (-47.0%), and Vietnam (-37.1%),
whereas the smallest TB case rate decline was among Mexico-born recent entrants (-12.0%)
(Table 2). The population of recent entrants fromMexico decreased (-50.1%), but the popula-
tions of recent entrants from China (+35.0%), Vietnam (+14.6%), and India (+14.3%) all
increased, and the population of recent entrants from the Philippines remained largely
unchanged (-2.4%).
Recent Entrants: Country of Origin, Categorized by TB Incidence Rate,
2007–2011
Excluding the top five countries of origin, case count declines occurred among recent entrants
from all groups, categorized by TB incidence rate, with the largest relative case count decline
from medium-incidence countries (-48.9%, -221 cases) (Fig 3). Recent entrants from all inci-
dence groups also experienced declines in TB case rate (Table 2). The populations of recent
entrants from low- (+1.3%) and high-incidence (+7.0%) countries both increased, but the pop-
ulation of recent entrants from medium-incidence countries decreased (-6.3%).
Factors Contributing to the Decline, 2007–2011
Overall, 69.6% of the case count decline was among recent entrants (1,013 of 1,456 cases).
Among recent entrants, an estimated 71.1% of the decline was from a decrease in the TB case
Fig 1. Tuberculosis case counts with Joinpoint regression among recent entrants, 2000–2014. Shaded bars indicate tuberculosis case counts among
recent entrants (foreign-born persons with <3 years since U.S. entry). The solid line represents a Joinpoint regression of tuberculosis case counts. Solid
circles represent statistically significant changes in trend in 2007 and 2011 (2000–2007 annual percent change, -1.7% [95% confidence interval {CI}, -3.5%,
+0.2%); 2007–2011 annual percent change, -11.4% (95%CI -17.4%, -5.1%)]; 2011–2014 annual percent change, -0.6% [95% CI, -7.3%, +6.5%]).
doi:10.1371/journal.pone.0147353.g001
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rate, and the remaining 28.9% was the result of a decrease in the recent entrant population.
When stratified by country of origin, 100% of the respective case count declines among recent
entrants from China, India, and Vietnam (and 95.5% from the Philippines) were found to be
the result of decreases in TB case rate. For recent entrants fromMexico, 80.7% of the case
count decline was attributable to the decreased population, and 19.3% was a result of a decrease
in TB case rate.
Non-recent entrants (3 years since U.S. entry) accounted for 30.4% of the overall foreign-
born case count decline (443 of 1,456 cases). Among non-recent entrants, 100% of the case
count decline was the result of a decrease in TB case rate—the non-recent entrant population
increased during the study period.
Overseas Culture-Based TB Screening by Country of Origin, 2007–2011
During 2007–2011, the proportion of the new entrant population (<1 year since U.S. entry)
with overseas culture-based TB screening varied by country of origin (Table 3). India, China,
and Mexico had the lowest proportion of new entrants who received overseas TB screening
(5.4%, 20.3%, and 23.7%, respectively), despite comprising the largest new entrant populations.
The majority of the new entrant population from the Philippines (51.7%) and Vietnam
(72.6%) received overseas culture-based TB screening during 2007–2011.
World Health Organization estimates [1] from 2007 and 2011 reveal declines in estimated
TB incidence in China (-12.8%), India (-10.4%), Vietnam (-10.1%), and the Philippines
(-6.8%). In contrast, Mexico had a slight increase in estimated TB incidence (+5.0%) (Table 4).
Transmission of TB among Recent Entrants in the United States, 2011
During January 1–September 30, 2011, of the 1,039 cases among recent entrants, 772 (74.3%)
had at least one positive culture result (Table 5). Among the 720 (93.3%) cases with a known
Table 1. Changes in tuberculosis case counts, population estimates, and tuberculosis case rates among foreign-born persons in the United
States, 2007 and 2011.








Among all foreign born
persons
7,529 6,073 -19.3 40,148 42,917 +6.9 18.8 14.2 -24.5
Recent versus non-recent
entrantsb
Recent 2,567 1,554 -39.5 4,152 3,632 -12.5 61.8 42.8 -30.8
Non-
recent
4,962 4,519 -8.9 35,996 39,285 +9.1 13.8 11.5 -16.6
Years since U.S. entry
<1 1,521 935 -38.5 1,449 1,318 -9.1 104.9 71.0 -32.4
1 to <2 557 330 -40.8 1,369 1,175 -14.2 40.7 28.1 -31.0
2 to <3 489 289 -40.9 1,334 1,140 -14.6 36.7 25.4 -30.8
3 to <6 1,005 838 -16.6 4,016 3,661 -8.8 25.0 22.9 -8.5
6 3,957 3,681 -7.0 31,979 35,624 +11.4 12.4 10.3 -16.5
a Source: American Community Survey [8].
b Recent entrants are foreign-born persons with <3 years since U.S. entry; non-recent entrants are foreign-born persons with 3 years since U.S. entry.
doi:10.1371/journal.pone.0147353.t001
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TB genotype, 30 (4.2%) were likely due to recent transmission and had at least one potential
source case identified. We estimated that 12–16 of the 720 cases (1.7%–2.2%) were likely due to
transmission from a recent entrant with infectious TB.
Discussion
We found an overall decline of 1,456 cases (-19.3%) among foreign-born persons during 2007–
2011. All foreign-born subpopulations, regardless of time since U.S. entry, experienced declines
in both TB case count and case rate.
We had hypothesized that the decline in TB cases among foreign-born persons was primar-
ily the result of a decreased TB case rate among recent entrants (<3 years since U.S. entry) and
a decreased number of foreign-born persons living in the United States (particularly recent
entrants). Our overall findings support these hypotheses. Specifically, we determined that the
majority (69.6%) of the case count decline was among recent entrants; 71.1% of the case count
decline among recent entrants was the result of decreased TB case rates, and 28.9% was from a
population decrease.
When we examined contributing factors to the decline among subpopulations of recent
entrants, we identified substantial heterogeneity by country of origin. Among Mexico-born
recent entrants, 80.7% of the case count decline was the result of a population decrease, and
only 19.3% was from a case rate decline, consistent with previously reported results [11]. These
findings imply that if immigration fromMexico were to markedly increase, the number of TB
Fig 2. Tuberculosis case counts and percent decline among foreign-born persons by years since U.S. entry, 2007 and 2011. Light shaded bars
represent tuberculosis case counts in 2007, and dark shaded bars represent tuberculosis case counts in 2011. Percentages indicate the percent decline in
case count for each group during 2007–2011.
doi:10.1371/journal.pone.0147353.g002
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cases among Mexico-born recent entrants would also be expected to increase. In contrast, the
case count decline among recent entrants among each of the other top five countries of origin
was almost entirely the result of a case rate decline and therefore might be less affected by
future immigration trends. These observations become particularly important in the context of
ongoing demographic shifts among foreign-born persons in the United States [18, 19, 24].
At least four major factors could explain the observed declines in TB case rates among
recent entrants: overseas culture-based TB screening, declining TB morbidity in the countries
of origin, changing composition of recent entrants (e.g., a disproportionate decrease in recent
entrants from high-incidence countries), and decreased transmission in the United States
among recent entrants.
Previous studies have assessed the benefits of culture-based overseas TB screening [25–29],
and a recent analysis specifically explored the contribution of culture-based overseas screening
to the decline in foreign-born TB incidence in the United States [30]. We found that the pro-
portion of recent entrants who received overseas culture-based TB screening varied greatly by
country of origin. During 2007–2011, only 23.7% of the new entrant population fromMexico
passed through overseas culture-based TB screening, in contrast with 72.6% of new entrant
population from Vietnam. Because we found a stable TB case rate among recent entrants from
Mexico and a large case rate decline among recent entrants from Vietnam, these data are
Fig 3. Tuberculosis case counts and percent decline among recent entrants, by country of origin or tuberculosis incidence in country of origin,
2007 and 2011. Light shaded bars represent tuberculosis case counts in 2007, and dark shaded bars represent tuberculosis case counts in 2011.
Percentages indicate the percent decline in case count for each group during 2007–2011. Recent entrants are foreign-born persons with <3 years since U.S.
entry. The top five countries of origin accounting for the greatest number of tuberculosis cases among foreign-born persons in the United States are listed;
cases among persons from other countries are classified according to tuberculosis incidence in the country of origin as low (<15 cases/100,000 persons),
medium (15–99 cases/100,000 persons), or high (100 cases/100,000 persons). Countries with unknown incidence rates were excluded. All incidence rates
used to categorize countries of origin are fromWorld Health Organization data [1] and expressed per 100,000 persons.
doi:10.1371/journal.pone.0147353.g003
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consistent with a contribution to TB case reduction from overseas culture-based TB screening,
particularly in countries where the screening covered a high percentage of the new entrant
population.
However, like Mexico, a smaller proportion of the new entrant population from India
(5.4%) and China (20.3%) passed through overseas culture-based TB screening during 2007–
Table 2. Changes in tuberculosis case counts, population estimates, and tuberculosis case rates among recenta entrants, 2007 and 2011.
Tuberculosis Case Count Population Estimateb
(Thousands)








County of origin, top five high
morbidityc
Mexico 481 211 -56.1 1,219 608 -50.1 39.5 34.7 -12.0
Philippines 343 163 -52.5 172 167 -2.4 199.9 97.3 -51.3
India 254 153 -39.8 257 294 +14.3 98.7 52.0 -47.3
Vietnam 129 93 -27.9 68 78 +14.6 188.5 118.6 -37.1
China 116 83 -28.4 195 263 +35.0 59.5 31.5 -47.0
Incidence in countries of origin,
excluding the top fived
High 754 582 -22.8 449 481 +7.0 167.5 119.1 -28.9
Medium 452 231 -48.9 1,006 943 -6.3 44.9 23.7 -47.4
Low 37 29 -21.6 681 690 +1.3 5.4 4.2 -22.6
a Recent entrants are foreign-born persons with <3 years since U.S. entry.
b Source: American Community Survey [8].
c The five countries of origin accounting for the greatest number of tuberculosis cases in the United States. In 2011, the estimated TB incidences in the
top five countries were: Mexico (21/100,000 persons), Philippines (303/100,000 persons), India (80/100,000 persons), Vietnam (180/100,000 persons),
China (75/100,000 persons) [1].
d Excluding cases from the top five countries of origin, we categorized the remaining cases of tuberculosis among recent entrants according to the
tuberculosis incidence in the country of origin: low (<15 cases/100,000 persons), medium (15–99 cases/100,000 persons), or high (100 cases/100,000
persons) [1].
doi:10.1371/journal.pone.0147353.t002









Number of New Entrants with
Overseas Culture-Based Screeningc
(Thousands)
Proportion of New Entrant Population
with Overseas Culture-Based
Screening (%)
Mexico October 2007 1,315 311 23.7
Philippines October 2007 290 150 51.7
India October 2010 571 31 5.4
Vietnam February 2008 135 98 72.6
China July 2009 441 89 20.3
a Foreign-born persons living in the United States for <1 year, regardless of visa status or mode of entry. Source: American Community Survey [8].
b These dates represent the transition from smear-based to culture-based overseas screening. Source: Centers for Disease Control and Prevention [22].
c Only refugees or persons applying for permanent resident visas must undergo overseas tuberculosis screening. Those applying for other visa types
(e.g., students, exchange visitors, temporary workers, tourists, and business travelers) and those who enter the United States without a visa (e.g.,
undocumented persons) are not required to receive overseas screening. Sources: U.S. Department of Homeland Security [12] and CDC’s Electronic
Disease Notification system [13].
doi:10.1371/journal.pone.0147353.t003
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2011, and yet recent entrants from India and China also experienced substantial declines in TB
case rates. These data demonstrate that, although overseas culture-based TB screening likely
contributed to the TB case rate decline for specific countries of origin (e.g., Vietnam and the
Philippines), other factors likely played a more prominent role in the TB case rate decline
Table 4. Changes in Estimated Overseas Tuberculosis Incidence for the Top Five Countries of Ori-
gina, 2007 and 2011.





Mexico 20 21 +5.0
Philippines 325 303 -6.8
India 201 180 -10.4
Vietnam 168 151 -10.1
China 86 75 -12.8
a The five countries of origin accounting for the greatest number of tuberculosis cases among foreign-born
persons in the United States.
b Source: World Health Organization [1].
doi:10.1371/journal.pone.0147353.t004




Cases among recent entrants 1,039
With at least one positive
culture result
772/1,039 74.3
With a genotype result 720/772 93.3
Due to recent transmissiond 30/720 4.2
By origin of source case








U.S.-born source case 3–4/720 0.4–
0.6
a Recent entrants are foreign-born persons with <3 years since U.S. entry; non-recent entrants are foreign-
born persons with 3 years since U.S. entry.
b Cases counted during January 1–September 30, 2011, in the U.S. National Tuberculosis Surveillance
System; cases from October 1–December 31, 2011, were excluded to allow an additional 3-month period
for belated identification of potential source cases.
c Range reflects low–high estimates. Low estimates include only scenarios where all potential source
cases are from a given group (e.g., foreign-born recent entrants). High estimates include scenarios where
at least one potential source case is from a given group.
d A given case was classified as due to recent transmission if at least one plausible source case was
identified based upon clinical characteristics, genotyping data, and temporal and geographic proximity to
the putative secondary case.
doi:10.1371/journal.pone.0147353.t005
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among recent entrants from other countries of origin (e.g., Mexico, India, and China). Prior
studies have explored the potential impact of extending overseas TB screening to additional
visa categories [28, 31] as well as testing and treating latent TB infection among refugees over-
seas [32]. While such programs might further reduce TB morbidity in the United States, these
efforts would likely have a limited impact on persons originating from Mexico, the vast major-
ity of whom enter the United States with a short-term visa or without a visa altogether [12, 19].
The second factor potentially contributing to the decline in TB case rates among recent
entrants is decreased TB incidence in each of the top five countries of origin. From 2007–2011,
there were declines in estimated TB incidence in China, India, Vietnam, and the Philippines,
but a relatively stable estimated TB incidence in Mexico. Based upon these data, it is possible
that declining morbidity in foreign countries contributed to the declining case rates seen
among recent entrants from China, Vietnam, India, and the Philippines. However, as recent
entrants may not be representative of the general population in the country of origin, the pre-
cise contribution of decreasing TB incidence overseas to the decline in TB cases in the United
States remains uncertain.
The third factor that could explain the decrease in TB case rates is the changing composition
of the recent entrant population. Excluding the top five countries of origin, the population of
recent entrants from medium-incidence countries decreased (-6.3%) during the study period,
while the population of recent entrants from low-incidence countries remained largely
unchanged (+1.3%), and the population of recent entrants from high-incidence countries
increased (+7.0%). There was a large decline in the recent entrant population from Mexico, but
the recent entrant populations from Vietnam and the Philippines (high-incidence countries) as
well as China and India (medium-incidence countries) all experienced increases or no change
(Philippines) during 2007–2011. These findings indicate that the changing composition of
recent entrants did not substantially contribute to the overall decline in TB case rates among
recent entrants.
The fourth factor that could explain a decrease in TB case rates is less TB transmission
among recent entrants. However, we found that a limited proportion of cases among recent
entrants were likely due to recent transmission (4.2%), and an even smaller proportion (1.7%–
2.2%) were likely due to transmission from a recent entrant source case. These findings are
consistent with prior studies that established relatively low rates of transmission among for-
eign-born persons in the United States [33, 34]. Although data on transmission was limited to
2011 (and we could not assess trends over time), the extremely small proportion of cases asso-
ciated with transmission make it unlikely that a change in transmission was a major contribu-
tor to the decline.
A substantial portion of the overall case count decline (30.4%) was among non-recent
entrants (3 year since U.S. entry), and was therefore not accounted for by our hypotheses.
Importantly, the case count decline among non-recent entrants was exclusively the result of a
decrease in TB case rates. These decreasing rates might reflect a birth-cohort effect from a
lower prevalence of latent TB infection among successive cohorts of immigrants [35]. This is of
particular interest, as we must consider that a substantial proportion of the decline observed
might be the result of global TB control efforts in foreign countries during the past several
decades—a reminder of the importance of domestic returns from investing in TB control over-
seas [36]. Another factor that could explain the observed decline among non-recent entrants is
improved TB control efforts in the United States through targeted testing and treatment of
latent TB infection. However, targeted testing has not previously focused on non-recent
entrants; therefore, this explanation seems less likely [37].
The substantial decline in TB case rate among non-recent entrants was an unexpected find-
ing, and has implications for future TB morbidity trends in the United States. Despite a
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substantial decline in TB case rate (-16.6%), an increase in the size of the non-recent entrant
population (+9.1%) dampened the reduction in TB cases. Non-recent entrants accounted for
73.8% of all cases among foreign-born persons in 2014, and if current trends continue, can be
expected to be the dominant driver of future TB epidemiology in the United States.
Because of the enormous size of the non-recent entrant population (an estimated 41.2 mil-
lion in 2014) [8], domestic efforts to reduce the TB case rate among this group (i.e., targeted
testing and treatment of latent TB infection) could have a profound impact on TB morbidity as
a whole in the United States. Although U.S. national guidelines recommend prioritizing testing
of foreign-born persons who have been in the United States for<5 years [37], recent evidence
suggests that rates of reactivation remain persistently elevated for years after arrival [17, 38]. At
the same time, providing targeted testing and treatment to the entirety of the foreign-born pop-
ulation might not be feasible, given current health system resources [39, 40]. Therefore, there is
an urgent need to identify a practical, prioritized approach to latent TB infection among for-
eign-born persons [41]. Studies that examine the cost-effectiveness of targeting foreign-born
persons with specific risk factors for reactivation [42] could be used to focus testing and treat-
ment of latent TB infection among this large and growing population.
One of the primary goals of TB surveillance is to understand trends in morbidity and to
shape public health policies. However, because of shifts in immigration and changes in the dis-
tribution of TB cases among the foreign-born population (especially with respect to duration
of time since U.S. entry), the standard approach to interpreting TB case counts and overall TB
case rates might not be adequate. For example, if immigration increases in the future, this
might result in an increase in foreign-born TB cases and be mistakenly interpreted as a failure
of TB control efforts. Conversely, a further reduction in the TB case rate among non-recent
entrants might result in an overall decline in cases among foreign-born persons, which might
mask a simultaneous increase among recent entrants.
Our analyses have several limitations. First, there is statistical variability in the timing of the
Joinpoint regression flexions, indicating the timing of the decline, and as a result, 2007–2011 is
an estimate. Second, in the transmission analysis, we included persons diagnosed with TB
<100 days after arrival, and therefore, might have misclassified cases as due to recent transmis-
sion in the United States that actually were due to transmission prior to U.S. entry. Third, as
we were only able to assess transmission for TB cases diagnosed in 2011, we were unable to spe-
cifically evaluate changes in transmission during 2007–2011. Fourth, while the American Com-
munity Survey does not exclude persons on the basis of immigration status, it is possible that
some proportion of undocumented persons are missed. Fifth, although a small proportion
(4.5%) of overall cases had unknown years since U.S. entry and/or country of origin, these
cases may differ from the overall study population. Sixth, persons may have passed through
Mexico en route from another Latin American country to the United States, and could have
been misclassified as Mexico-born.
Overall, we found that during 2007–2011, there was an abrupt decline in reported TB cases
among foreign-born persons living in the United States, and this decline was evident among
both recent and non-recent entrants. Among recent entrants, the decline was associated with a
decrease in TB case rate as well as a decrease in population, but this varied by country of origin.
In addition, non-recent entrants also substantially contributed to the decline, exclusively as a
result of a decreasing TB case rate. Future TB morbidity trends among recent entrants may be
closely linked to patterns of immigration and emigration. Strategies that impact both recent
and non-recent entrants (e.g., investment in overseas TB control) as well as those that focus on
non-recent entrants (e.g., targeted testing of high-risk subpopulations among non-recent
entrants) will be necessary to achieve further declines in TB morbidity among foreign-born
persons.
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